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Objective: This retrospective cohort study seeks to identify risk factors associated with com-
plications following posterior cervical laminectomy and fusion (PCLF) surgery.
Methods: Adults undergoing PCLF from 2012 through 2018 at a single center were identi-
fied. Demographic and radiographic data, surgical characteristics, and complication rates 
were compared. Multivariate logistic regression models identified independent predictors 
of complications following surgery.
Results: A total of 196 patients met the inclusion criteria and were included in the study. 
The medical, surgical, and overall complication rates were 10.2%, 23.0%, and 29.1% re-
spectively. Risk factors associated with medical complications in multivariate analysis in-
cluded impaired ambulation status (odds ratio [OR], 2.27; p = 0.02) and estimated blood 
loss over 500 mL (OR, 3.67; p = 0.02). Multivariate analysis revealed preoperative narcotic 
use (OR, 2.43; p = 0.02) and operative time (OR, 1.005; p = 0.03) as risk factors for surgi-
cal complication, whereas antidepressant use was a protective factor (OR, 0.21; p = 0.01). 
Overall complication was associated with preoperative narcotic use (OR, 1.97; p = 0.04) 
and higher intraoperative blood loss (OR, 1.0007; p = 0.03).
Conclusion: Preoperative narcotic use and estimated blood loss predicted the incidence of 
complications following PCLF for CSM. Ambulation status was a significant predictor of 
the development of a medical complication specifically. These results may help surgeons in 
counseling patients who may be at increased risk of complication following surgery.
Keywords: Posterior cervical fusion, Complication, Risk factor, Narcotics, Cervical spon-
dylotic myelopathy
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INTRODUCTION
Cervical spondylotic myelopathy (CSM) is a major cause of 
disability in the United States.1 When compared to patients 
with other chronic debilitating diseases, those with CSM had a 
high rate of baseline disability and increased socioeconomic 
burden.1 It is estimated that 1.6 per 100,000 people have symp-
tomatic CSM requiring surgery, and its incidence continues to 
rise with the aging patient population.2,3 The onset of symptoms 
is usually insidious, with patients experiencing a variety of dif-
ferent symptoms which may include neck pain with or without 
associated radiculopathy, decreased hand dexterity, gait imbal-
ance, and bowel or bladder incontinence.4,5 Posterior cervical 
laminectomy and fusion (PCLF) remain a highly effective treat-
ment strategy for patients with multi-level disease and signifi-
cant dorsal compression. It may become even more utilized as 
the aging population demonstrates the increasing severity of 
cervical spondylosis.6,8
Complication rates for procedures that treat CSM are esti-
mated to be about 10.4% overall, and the reported complication 
rates for PCLF are even greater, ranging from 12.5% to 16.9% 
in the existing literature.9-12 Therefore, it is important to identify 
potential risk factors in order to optimize clinical outcomes. A 
recent study found that hypoalbuminemia, indicating malnu-
trition, was a significant risk factor for complication and pro-
longed length of stay following PCLF surgery.10 However, few 
others have examined potential predictors of complications as-
sociated with PCLF specifically.13 Our study seeks to identify 
potential risk factors for medical and surgical complications 
following PCLF surgery.
MATERIALS AND METHODS
1. Patient Population
The electronic medical records of consecutive patients who 
underwent PCLF were reviewed from May 2012 through July 
2018 at a single, high-volume academic spine center. Exclusion 
criteria included non-CSM diagnosis such as vertebral neoplasm 
or acute vertebral fracture, and patients who had concurrent or 
staged anterior cervical spine surgery. The perioperative records 
and imaging were reviewed and analyzed. Clinical records and 
imaging up to 3 months postoperatively were reviewed to iden-
tify adverse events. Medical research was conducted according 
to the World Medical Association Declaration of Helsinki. This 
study was approved by our Institutional Committee on Human 
Research as the Institutional Review Board of record (study #18-
24941). Patient consent was not required given that the only re-
cord linking the subject and the research would be the informed 
consent form and the principal risk of the present study is the 
potential harm resulting from a breach of confidentiality.
2. Data Collection
Demographic variables examined included age, sex, smoking 
status (current smoker or never/former smoker), insurance 
(private insurance, Medicare, Medicaid, or uninsured), revision 
surgery, and American Society of Anesthesiologists (ASA) physi-
cal status classification grades. Neurologic risk factors included 
an ambulation status (independent, assisted, or nonambulato-
ry), primary indication for surgery (radiculopathy or myelopa-
thy), and the presence of any motor deficit. Comorbidities ex-
amined included diabetes, coronary artery disease (CAD), psy-
chiatric disorder, chronic renal disease, chronic pulmonary dis-
ease, arthritis of a major joint (shoulder, hip, or knee), and os-
teoporosis. Preoperative medications examined included mus-
cle relaxants, antidepressants, antianxiety medication, and nar-
cotic use. Preoperative medication use was defined as the pres-
ence of any active prescription at the time of surgery. Preopera-
tive radiographic data examined included cervical lordosis, T1 
slope, cervical sagittal vertical axis, chin-brow vertical angle, 
proximal junctional angle, distal junctional angle, sacral slope, 
pelvic incidence, pelvic tilt, lumbar lordosis, and thoracic ky-
phosis. All radiographic measurements were taken of sagittal 
plain film X-rays using eUnity software (ver. 6.3.0.1-4; Client 
Outlook Inc., Waterloo, ON, Canada). Measurements were 
made by 2 observers using radiographic parameters defined in 
previous literature.7,14,15 Interrater reliability, as measured by in-
traclass correlation, was 0.947 (95% confidence interval [CI], 
0.943–0.951). Surgical characteristics examined included num-
ber of vertebrae fused, whether fusion crossed the cervicotho-
racic junction, estimated blood loss (EBL), operative time and 
whether laminectomy was performed, concurrently or in stages.
The primary outcome measured was the 30-day complica-
tion rate, defined as the proportion of patients who experienced 
an adverse event. This was refined further into 3 categories: med-
ical complications, surgical complications, and overall compli-
cation. Medical complications included urinary tract infection 
(UTI), anemia, thrombotic events, arrhythmia, cardiac arrest, 
pneumonia, sepsis, and death. Surgical complications included 
dysphagia, durotomy, surgical site infection, seroma, new neu-
rologic deficit, implant malposition, and surgical revision with-
in 30 days. Overall complication was defined as the presence of 
a medical complication, a surgical complication, or both.
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Demographic Value
Pelvic incidence (°)  58.89 ± 14.46
Pelvic tilt (°)    21.70 ± 11.98
Lumbar lordosis (°)  48.792 ± 15.82
Thoracic kyphosis (°)    31.31 ± 11.64
SVA (mm)   37.73 ± 40.92
Procedure
Laminectomy performed 184 (93.9)
No. of vertebrae fused   4.2 ± 1.9
EBL over 500 mL 28 (14.3)
Operative time (min) 221.4 ± 97.7
Values are presented as mean ± standard deviation or number (%).
ASA, American Society of Anesthesiologists physical status classifi-
cation; CAD, coronary artery disease; cSVA, cervical sagittal vertical 
axis; SVA, sagittal vertical axis; EBL, estimated blood loss. 
Table 1. ContinuedTable 1. Patient demographics
Demographic Value
Age (yr) 63 ± 11.37
Female sex 90 (45.9)
Current smoker 17 (8.7)
Insurance
   Medicare 110 (56.1)
   Medicaid 24 (12.2)
   Private Insurance 90 (45.9)
   Uninsured 2 (1.0)
Revision surgery 20 (10.2)
ASA grade III+ 90 (45.9)
Neurologic
Ambulatory status
   Independent 135 (68.9)
   Assisted 36 (18.4)
   Nonambulatory 25 (12.7)
Indication for surgery
   Radiculopathy 28 (14.3)
   Myelopathy 155 (79.1)
   Cervical instability 12 (6.1)
   Motor deficit 132 (67.3)
Comorbidities
Diabetes 33 (16.8)
CAD 14 (7.1)
Psychiatric disorder 69 (35.2)
Chronic renal disease 12 (6.1)
Chronic pulmonary disease 21 (10.7)
Arthritis 32 (16.3)
Osteoporosis 20 (10.2)
Preoperative medications
Muscle relaxants 39 (19.9)
Antidepressant 37 (18.9)
Antianxiety 34 (17.3)
Narcotics 101 (51.5)
Preoperative radiographic parameters 
Cervical lordosis (°)  8.53 ± 14.61
T1 slope (°)  29.37 ± 10.86
cSVA (mm) 33.82 ± 17.61
Chin-brow vertical angle (°)  1.94 ± 8.79
Proximal junctional angle (°)  -34.25 ± 18.53
Distal junctional angle (°)  0.09 ± 6.44
Sacral slope (°)  38.12 ± 11.84
(Continued to the next)
3. Statistical Analysis
Continuous risk factors are presented as means and standard 
deviations. Categorical risk factors are presented as the number 
of cases and percentages. Univariate analysis was used to iden-
tify predictors of postoperative complication. Chi-square, Fisher 
exact, and Student t-tests were performed and OR, 95% CI, and 
p-values were generated. Variables significant at p= 0.20 were 
included in multivariate analysis. Patients with missing data for 
any included variable were omitted. A stepwise multivariate lo-
gistic regression was performed to examine each variable’s rela-
tive contribution and calculate the adjusted OR, CI, and p-val-
ues. Statistical analyses were performed using custom scripts 
(RStudio software ver. 1.1.463; RStudio, Boston, MA, USA) 
running on Windows 10 Pro.
RESULTS
1. Demographics
A total of 291 patients were initially identified from the elec-
tronic database. There were 81 patients excluded due to non-
CSM diagnosis such as vertebral neoplasm or acute vertebral 
fracture, or other diagnoses unrelated to CSM, and another 14 
patients were excluded due to concurrent or staged anterior 
cervical surgery. After applying the exclusion criteria, the peri-
operative records and imaging studies of the remaining 196 pa-
tients were reviewed and analyzed. Clinical records and imag-
ing up to 3 months postoperatively were reviewed to identify 
adverse events.
The demographics of this cohort are provided in Table 1. The 
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mean age was 63 ± 11.37 years, there were 90 female patients 
(45.9%) and 17 patients (8.7%) were smokers. There were 20 
revision cases (10.2%), and 90 patients (45.9%) had ASA physi-
cal status classification grade of III or greater. Most patients 
ambulated independently (n= 135, 68.9%), but many also had 
one or more motor deficit (n= 132, 67.3%). The most common 
comorbidities were psychiatric disorders (n= 69, 35.2%), diabe-
tes (n= 33, 16.8%), and arthritis (n= 32, 16.3%). Approximately 
half of patients (n= 101, 51.5%) reported preoperative narcotic 
use. Approximately 20% of patients had preoperative use of 
muscle relaxants (n= 39, 19.9%), antidepressants (n= 37, 18.9%), 
and antianxiety medications (n= 34, 17.4%). Preoperative im-
aging showed an average cervical lordosis of 8.5°± 14.6°, a T1 
slope of 29.3°± 10.9°, and a cervical sagittal vertebral axis (cSVA) 
of 33.8± 17.6 mm. The average number of fused levels was 4.2±  
1.9, with a mean operative time of 221.4± 97.7 minutes.
2. Postoperative Complications
The 30-day postoperative complication rates are shown in 
Table 2. Medical complications occurred in 20 patients (10.2%), 
the most common of which were acute blood loss anemia (n=  
7, 3.6%), UTIs (n = 5, 2.6%), and cardiac arrhythmias (n = 4, 
2.0%). Major medical complications occurred in 6 patients 
(3.1%), with 2 cases of pneumonia, one cardiac arrest, and one 
death within 30 days of surgery. Surgical complications occurred 
in 45 patients (23.0%). Of these, the most common complica-
tions included a new neurologic deficit following surgery (n= 16, 
8.2%), durotomy (n = 11, 5.6%), and wound infections (n = 7, 
3.6%). Three patients (1.5%) had malpositioned implants or 
grafts and required revision surgery within 30 days. Overall, 57 
patients (29.1%) experienced at least one medical or surgical 
complication.
3. Univariate Analysis
Univariate analysis of risk factors for postoperative complica-
tions is presented in Table 3. Significant predictors for medical 
complication included EBL over 500 mL (OR, 3.97; p= 0.01), 
thoracic kyphosis (OR, 1.07; p= 0.01), cSVA (OR, 1.03; p= 0.04), 
and operative time (OR, 1.007; p= 0.004). ASA physical status 
classification grade was not a significant predictor at the uni-
variate level (OR, 2.25; p= 0.09). There were no significant risk 
factors for surgical complication on univariate analysis. Overall 
complication incidence was predicted by EBL over 500 mL (OR, 
2.91; p= 0.01) operative time (OR, 1.004; p= 0.03).
4. Multivariate Analysis
Each multivariate regression model initially included all vari-
ables significant at p< 0.20 on univariate analysis and was iter-
ated until only variables significant at p< 0.05 remained. Poten-
Table 2. Incidence of 30-day complications
Complication No. (%)
Medical complications
Minor 18 (9.2)
   Urinary tract infection 5 (2.6)
   Anemia 7 (3.6)
   Excessive blood loss ( > 3 L) 1 (0.5)
   Pneumothorax  0 (0)
   Deep vein thrombosis 3 (1.5)
   Arrhythmia* 4 (2.0)
Major 6 (3.1)
   Myocardial infarction 0 (0)
   Cardiac arrest 1 (0.5)
   Pneumonia 2 (1.0)
   Pulmonary embolism 1 (0.5)
   Cerebrovascular event 1 (0.5)
   Sepsis 1 (0.5)
   Death 1 (0.5)
Any medical complication 20 (10.2)
Surgical complications
Minor 39 (19.9)
   Dysphagia 5 (2.6)
   Vocal cord paralysis 1 (0.5)
   Pain control 4 (2.0)
   Durotomy 11 (5.6)
   Superficial wound infection 4 (2.0)
   Cerebrospinal fluid leak 0 (0)
   Seroma 5 (2.6)
   Wound dehiscence 0 (0)
   New neurologic deficit (weakness, palsy, numbness) 16 (8.2)
Major 8 (3.8)
   Deep wound infection 3 (1.5)
   Implant/graft malposition 3 (1.5)
   Wrong level surgery 0 (0)
   Pseudomeningocele 0 (0)
   Revision required within 30 days 3 (1.5)
Any surgical complication 45 (23.0)
Any medical or surgical complication 57 (29.1)
*Arrhythmia includes atrial fibrillation, premature atrial contraction, 
premature ventricular contraction, and sinus tachycardia.
Risk Factors for Complication Following Posterior Cervical FusionBadiee RK, et al.
https://doi.org/10.14245/ns.1938198.099552 www.e-neurospine.org
Ta
bl
e 3
. U
ni
va
ria
te
 an
aly
sis
 o
f p
re
di
ct
or
s o
f 3
0-
da
y c
om
pl
ica
tio
ns
Va
ria
bl
e
M
ed
ica
l  
co
m
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
Su
rg
ica
l  
co
m
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
A
ny
 co
m
-
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
D
em
og
ra
ph
ics
   A
ge
 (y
r)
 
 
 
    
  <
65
9 
(8
.4
)
Re
f
Re
f
24
 (2
2.
4)
Re
f
Re
f
29
 (2
.1
)
Re
f
Re
f
    
  ≥
65
11
 (1
2.
4)
1.
02
 (0
.9
8–
1.
06
)
0.
43
21
 (2
3.
6)
1.
01
 (0
.9
8–
1.
04
)
0.
61
28
 (3
1.
5)
1.
01
 (0
.9
9–
1.
04
)
0.
38
   S
ex
    
  M
al
e
14
 (1
3.
2)
Re
f
Re
f
25
 (2
3.
6)
Re
f
Re
f
34
 (3
2.
1)
Re
f
Re
f
    
  F
em
al
e
6 
(6
.7
)
0.
47
 (0
.1
6–
1.
23
)
0.
14
20
 (2
0.
2)
0.
93
 (0
.4
7–
1.
80
)
0.
43
23
 (2
5.
6)
0.
73
 (0
.3
9–
1.
35
)
0.
32
   S
m
ok
in
g 
sta
tu
s
    
  N
ev
er
 o
r f
or
m
er
 sm
ok
er
20
 (1
1.
5)
Re
f
Re
f
35
 (2
0.
1)
Re
f
Re
f
47
 (2
7.
0)
Re
f
Re
f
    
  C
ur
re
nt
 sm
ok
er
0 
(0
)
N
/A
N
/A
6 
(3
5.
3)
2.
17
 (0
.7
1–
6.
11
)
0.
14
6 
(3
5.
3)
1.
47
 (0
.4
8–
4.
10
)
0.
54
M
ed
ica
re
13
 (1
1.
8)
1.
51
 (0
.5
9–
4.
19
)
0.
40
28
 (2
5.
5)
1.
39
 (0
.7
1–
2.
78
)
0.
62
34
 (3
0.
9)
1.
23
 (0
.6
6–
2.
31
)
0.
52
M
ed
ica
id
2 
(8
.3
)
0.
78
 (0
.1
2–
2.
95
)
0.
75
5 
(2
0.
8)
0.
87
 (0
.2
7–
2.
32
)
0.
55
7 
(2
9.
2)
1.
00
 (0
.3
6–
2.
48
)
0.
99
Pr
iv
at
e i
ns
ur
an
ce
9 
(1
0.
0)
0.
96
 (0
.3
7–
2.
43
)
0.
93
19
 (2
1.
1)
0.
82
 (0
.4
2–
1.
61
)
0.
65
25
 (2
7.
8)
0.
89
 (0
.4
8–
1.
65
)
0.
71
U
ni
ns
ur
ed
0 
(0
)
0 
(0
–N
aN
)
1
1 
(5
0.
0)
3.
41
 (0
.1
3–
87
.3
9)
0.
36
1 
(5
0.
0)
2.
46
 (0
.1
0–
63
.0
4)
0.
53
Re
vi
sio
n 
su
rg
er
y
   N
o
17
 (9
.7
)
Re
f
Re
f
39
 (2
2.
3)
Re
f
Re
f
51
 (2
9.
1)
Re
f
Re
f
   Y
es
3 
(1
5.
0)
1.
64
 (0
.3
6–
5.
54
)
0.
46
6 
(3
0.
0)
1.
49
 (0
.5
0–
4.
00
)
0.
69
6 
(3
0.
0)
1.
04
 (0
.3
5–
2.
75
)
0.
94
A
SA
 g
ra
de
   
<I
II
7 
(6
.6
)
Re
f
Re
f
23
 (2
1.
7)
Re
f
Re
f
28
 (2
6.
4)
Re
f
Re
f
   I
II+
13
 (1
4.
4)
2.
25
 (0
.9
0–
6.
19
)
0.
09
22
 (2
4.
4)
1.
07
 (0
.5
6–
2.
06
)
1
29
 (3
2.
2)
1.
21
 (0
.6
7–
2.
23
)
0.
53
N
eu
ro
lo
gi
c
A
m
bu
lat
or
y s
ta
tu
s
1.
65
 (0
.9
1–
2.
90
)
0.
09
1.
07
 (0
.6
6–
1.
68
)
0.
73
1.
21
 (0
.7
9–
1.
84
)
0.
38
   I
nd
ep
en
de
nt
10
 (7
.4
)
29
 (2
1.
5)
36
 (2
6.
7)
   A
ss
ist
ed
6 
(1
6.
7)
11
 (3
0.
6)
13
 (3
6.
1)
   N
on
am
bu
lat
or
y
4 
(1
6.
0)
5 
(2
0.
0)
8 
(3
2.
0)
In
di
ca
tio
n 
fo
r s
ur
ge
ry
2.
21
 (0
.7
8–
6.
58
)
0.
15
1.
17
 (0
.5
7–
2.
46
)
0.
96
1.
15
 (0
.5
9–
2.
30
)
0.
68
   R
ad
ic
ul
op
at
hy
0 
(0
)
6 
(2
1.
4)
6 
(2
1.
4)
   M
ye
lo
pa
th
y
16
 (1
0.
3)
36
 (2
3.
2)
46
 (2
9.
7)
   M
ot
or
 d
ef
ici
t
14
 (1
0.
6)
1.
04
 (0
.4
0–
2.
94
)
0.
94
33
 (2
5.
0)
1.
57
 (0
.7
5–
3.
48
)
0.
33
40
 (3
0.
3)
1.
25
 (0
.6
4–
2.
49
)
0.
52
Co
m
or
bi
di
tie
s
D
ia
be
te
s
6 
(1
8.
2)
2.
33
 (0
.7
7–
6.
39
)
0.
11
8 
(2
4.
2)
1.
07
 (0
.4
2–
2.
49
)
0.
69
11
 (3
3.
3)
1.
25
 (0
.5
5–
2.
74
)
0.
58
Co
ro
na
ry
 ar
te
ry
 d
ise
as
e
3 
(2
1.
4)
2.
61
 (0
.5
5–
9.
39
)
0.
17
5 
(3
5.
7)
1.
94
 (0
.5
7–
5.
96
)
0.
19
6 
(4
2.
9)
1.
90
 (0
.6
0–
5.
73
)
0.
26
(C
on
tin
ue
d 
to
 th
e n
ex
t p
ag
e)
Risk Factors for Complication Following Posterior Cervical FusionBadiee RK, et al.
https://doi.org/10.14245/ns.1938198.099  www.e-neurospine.org  553
Va
ria
bl
e
M
ed
ica
l  
co
m
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
Su
rg
ica
l  
co
m
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
A
ny
 co
m
-
pl
ica
tio
n
O
R 
 
(9
5%
 C
I)
p-
va
lu
e
Ps
yc
hi
at
ric
 d
iso
rd
er
10
 (1
4.
5)
1.
98
 (0
.7
7–
5.
09
)
0.
15
14
 (2
0.
3)
0.
79
 (0
.3
8–
1.
58
)
0.
52
22
 (3
1.
9)
1.
23
 (0
.6
4–
2.
32
)
0.
52
Ch
ro
ni
c r
en
al
 d
ise
as
e
1 
(8
.3
)
0.
78
 (0
.0
4–
4.
36
)
0.
82
4 
(3
3.
3)
1.
72
 (0
.4
4–
5.
75
)
0.
32
4 
(3
3.
3)
1.
22
 (0
.3
1–
4.
04
)
0.
76
Ch
ro
ni
c p
ul
m
on
ar
y d
ise
as
e
0 
(0
)
0 
(0
–N
aN
)
0.
08
4 
(3
3.
3)
0.
52
 (0
.1
2–
1.
63
)
0.
39
4 
(3
3.
3)
0.
37
 (0
.0
8–
1.
14
)
0.
12
A
rth
rit
is
2 
(6
.3
)
1.
81
 (0
.5
5–
5.
14
)
0.
28
6 
(1
8.
8)
0.
73
 (0
.2
6–
1.
79
)
0.
97
10
 (3
1.
3)
1.
11
 (0
.4
7–
2.
48
)
0.
80
O
ste
op
or
os
is
3 
(1
5.
0)
2.
47
 (0
.6
5–
7.
75
)
0.
14
6 
(3
0.
0)
1.
48
 (0
.5
0–
3.
97
)
0.
13
8 
(4
0.
0)
1.
70
 (0
.6
3–
4.
37
)
0.
28
Pr
eo
pe
ra
tiv
e m
ed
ica
tio
ns
M
us
cle
 re
la
xa
nt
s
3 
(7
.7
)
0.
67
 (0
.1
5–
2.
14
)
0.
54
7 
(1
7.
9)
0.
69
 (0
.2
6–
1.
62
)
0.
43
9 
(2
3.
1)
0.
69
 (0
.2
9–
1.
50
)
0.
36
A
nt
id
ep
re
ss
an
t
6 
(1
6.
7)
1.
96
 (0
.6
5–
5.
32
)
0.
20
4 
(1
0.
8)
0.
35
 (0
.1
0–
0.
95
)
0.
06
10
 (2
7.
0)
0.
89
 (0
.3
8–
1.
93
)
0.
77
A
nt
ia
nx
iet
y
7 
(2
1.
2)
1.
19
 (0
.3
2–
3.
53
)
0.
77
9 
(2
6.
5)
1.
28
 (0
.5
2–
2.
90
)
0.
72
11
 (3
2.
4)
1.
21
 (0
.5
3–
2.
64
)
0.
64
N
ar
co
tic
s
15
 (1
5.
0)
1.
47
 (0
.5
8–
3.
91
)
0.
43
28
 (2
7.
7)
1.
76
 (0
.9
0–
3.
53
)
0.
10
35
 (3
4.
7)
1.
76
 (0
.9
4–
3.
33
)
0.
07
Pr
eo
pe
ra
tiv
e r
ad
io
gr
ap
hi
c p
ar
am
et
er
s
Ce
rv
ica
l l
or
do
sis
1.
01
 (0
.9
8–
1.
05
)
0.
59
1.
00
 (0
.9
7–
1.
02
)
0.
91
1.
00
 (0
.9
8–
1.
02
)
0.
97
T1
 sl
op
e
1.
01
 (0
.9
8–
1.
04
)
0.
26
1.
01
 (0
.9
8–
1.
04
)
0.
48
1.
00
 (0
.9
8–
1.
04
)
0.
67
cS
VA
1.
03
 (1
.0
0–
1.
06
)
0.
04
1.
01
 (0
.9
9–
1.
03
)
0.
17
1.
02
 (0
.9
9–
1.
04
)
0.
11
Ch
in
-b
ro
w
 ve
rti
ca
l a
ng
le
1.
06
 (0
.9
4–
1.
19
)
0.
30
0.
98
 (0
.9
0–
1.
06
)
0.
67
1.
01
 (0
.9
3–
1.
08
)
0.
89
Pr
ox
im
al
 ju
nc
tio
na
l a
ng
le
1.
00
 (0
.9
5–
1.
05
)
0.
98
0.
99
 (0
.9
6–
1.
01
)
0.
43
0.
99
 (0
.9
7–
1.
02
)
0.
58
D
ist
al
 ju
nc
tio
na
l a
ng
le
1.
04
 (0
.9
4–
1.
16
)
0.
50
1.
02
 (0
.9
5–
1.
10
)
0.
63
1.
00
 (0
.9
5–
1.
07
)
0.
90
Sa
cr
al
 sl
op
e
1.
04
 (0
.9
8–
1.
09
)
0.
18
1.
00
 (0
.9
6–
1.
04
)
0.
97
1.
02
 (0
.9
9–
1.
05
)
0.
38
Pe
lv
ic 
in
cid
en
ce
1.
01
 (0
.9
7–
1.
06
)
0.
56
1.
01
 (0
.9
8–
1.
04
)
0.
64
1.
01
 (0
.9
8–
1.
04
)
0.
40
Pe
lv
ic 
til
t
0.
97
 (0
.9
2–
1.
03
)
0.
40
1.
00
 (0
.9
7–
1.
04
)
0.
84
1.
00
 (0
.9
6–
1.
03
)
0.
80
Lu
m
ba
r l
or
do
sis
1.
03
 (0
.9
9–
1.
07
)
0.
17
1.
01
 (0
.9
8–
1.
04
)
0.
51
1.
01
 (0
.9
9–
1.
04
)
0.
34
Th
or
ac
ic 
ky
ph
os
is
1.
07
 (1
.0
2–
1.
14
)
0.
01
1.
03
 (0
.9
9–
1.
07
)
0.
14
1.
03
 (0
.9
9–
1.
06
)
0.
10
SV
A
0.
99
 (0
.9
8–
1.
01
)
0.
34
1.
00
 (0
.9
9–
1.
01
)
0.
99
1.
00
 (0
.9
9–
1.
01
)
0.
89
Pr
oc
ed
ur
e
La
m
in
ec
to
m
y p
er
fo
rm
ed
20
 (1
1.
0)
0.
54
 (0
.1
3–
3.
71
)
0.
45
43
 (2
3.
4)
1.
52
 (0
.3
8–
10
.1
7)
0.
59
54
 (2
9.
3)
1.
25
 (0
.3
6–
5.
78
)
0.
74
Le
ng
th
 o
f f
us
io
n
1.
19
 (0
.9
4–
1.
51
)
0.
14
1.
03
 (0
.8
6–
1.
22
)
0.
78
1.
05
 (0
.9
0–
1.
23
)
0.
54
Es
tim
at
ed
 b
lo
od
 lo
ss
 (p
er
 m
L)
1.
00
1 
(1
.0
0–
1.
00
2)
0.
00
4
1.
00
 (1
.0
0–
1.
00
)
0.
22
1.
00
05
 (1
.0
00
03
–1
.0
01
)
0.
11
    
  ≤
50
0 
m
L
13
 (7
.7
)
Re
f
Re
f
35
 (2
0.
8)
Re
f
Re
f
43
 (2
5.
6)
Re
f
Re
f
    
  >
50
0 
m
L
7 
(2
5.
0)
3.
97
 (1
.3
6–
10
.9
1)
0.
01
10
 (3
5.
7)
2.
11
 (0
.8
7–
0.
91
)
0.
09
15
 (5
0.
0)
2.
91
 (1
.2
8–
6.
64
)
0.
01
O
pe
ra
tiv
e t
im
e (
m
in
)
1.
00
7 
(1
.0
03
–1
.0
1)
0.
00
4
1.
00
3 
(1
.0
0–
1.
00
6)
0.
10
1.
00
4 
(1
.0
0–
1.
01
)
0.
03
Va
lu
es
 p
re
se
nt
ed
 as
 n
um
be
r (
%
) u
nl
es
s o
th
er
w
ise
 in
di
ca
te
d.
 
O
R,
 o
dd
s r
at
io
; C
I, 
co
nf
id
en
ce
 in
te
rv
al
; A
SA
, A
m
er
ica
n 
So
cie
ty
 o
f A
ne
sth
es
io
lo
gi
sts
 p
hy
sic
al
 st
at
us
 cl
as
sif
ica
tio
n;
 C
A
D
, c
or
on
ar
y 
ar
te
ry
 d
ise
as
e; 
cS
VA
, c
er
vi
ca
l s
ag
itt
al
 ve
rti
ca
l a
xi
s; 
SV
A
, 
sa
gi
tta
l v
er
tic
al
 ax
is;
 N
/A
, n
ot
 ap
pl
ica
bl
e; 
N
aN
, n
ot
 a 
nu
m
be
r. 
Ta
bl
e 3
. C
on
tin
ue
d
Risk Factors for Complication Following Posterior Cervical FusionBadiee RK, et al.
https://doi.org/10.14245/ns.1938198.099554 www.e-neurospine.org
tial risk factors for medical complications included ambulation 
status, indication for surgery, several comorbidities (diabetes, 
CAD, psychiatric disorders, osteoporosis), preoperative antide-
pressant use, ASA score, cSVA, lumbar lordosis, thoracic ky-
phosis, length of fusion, EBL, and operative time (Table 4). Of 
these, ambulation status (OR, 2.27; p= 0.02), EBL over 500 mL 
(OR, 3.67; p= 0.02), and thoracic kyphosis (OR, 1.08; p= 0.004) 
emerged as significant predictors. Impaired ambulation was 
significantly associated with increased incidence of postopera-
tive UTI (p= 0.004) (Supplementary Table 1) and EBL greater 
than 500 mL was associated with acute anemia (p= 0.006, Sup-
plementary Table 2).
Variables included in the surgical complication model includ-
ed smoking, CAD, osteoporosis, preoperative antidepressant 
and narcotic use, cSVA, thoracic kyphosis, EBL, and operative 
time. Of these, preoperative narcotic use (OR, 2.43; p = 0.02) 
and operative time (OR, 1.005; p = 0.03) were risk factors for 
surgical complication, whereas preoperative antidepressant use 
(OR, 0.21; p= 0.01) was a protective factor (Table 5). More spe-
cifically, operative time was significantly associated with incre-
ased incidence of dysphagia (p= 0.01) (Supplementary Table 3). 
Independent risk factors for overall postoperative complication 
were narcotic use (OR, 1.97; p = 0.04) and EBL (OR, 1.0007; 
p= 0.03) (Table 6), the latter of which was associated with new 
postoperative neurologic deficit (p= 0.02) (Supplementary Ta-
ble 2).
Table 5. Multivariate logistic regression of risk factors for 30-
day surgical complication
Risk factor Odds ratio 95% CI p-value
Antidepressant use 0.21 0.05 0.64 0.01*
Narcotic use 2.43 1.17 5.18 0.02*
Operative time (min) 1.005 1.00 1.01 0.03*
CI, confidence interval.
*p < 0.05.
Table 6. Multivariate logistic regression of risk factors for 30-
day overall complication
Risk factor Odds ratio 95% CI p-value
Narcotic use 1.97 1.03 3.82 0.04*
EBL over 500 mL  1.0007 1.00002 1.002 0.03*
CI, confidence interval; EBL, estimated blood loss.
*p < 0.05.
Table 4. Multivariate logistic regression of risk factors for 30-
day medical complication
Risk factor Odds ratio 95% CI p-value
Impaired ambulation 2.27 1.14 4.50 0.02*
Thoracic kyphosis (°) 1.08 1.03 1.14 0.004*
EBL over 500 mL 3.67 1.15 11.27 0.02*
CI, confidence interval; EBL, estimated blood loss.
*p < 0.05.
DISCUSSION
The present study utilized a retrospective chart review to 
identify pre- and intraoperative predictors of complication fol-
lowing PCLF surgery. We found statistically significant associa-
tions between medical complications and impaired preopera-
tive ambulation status, and increased EBL, and increased pre-
operative thoracic kyphosis. Surgical complication was associ-
ated with preoperative narcotic use and increased operative 
time. Finally, patients with preoperative narcotic use and intra-
operative blood loss > 500 mL had statistically significant in-
creased odds of overall complication following PCLF surgery.
The overall complication rate of 29.1% in this study is higher 
than those previously reported in the literature.9,11,12,16,17 This is 
mainly due to the expanded definition of “complication” used 
in our study compared to that of the NSQIP database, which is 
utilized in many previous studies.18 We included minor medical 
complications such as UTI, postoperative anemia, transient 
cardiac arrhythmia, and other surgical complications inherent 
to spinal surgery such as incidental durotomy and transient 
dysphagia were also included. In addition, new neurological 
deficits in this study included postoperative numbness and tran-
sient worsening weakness, which usually improved overtime. 
Excluding these minor complications from the analysis, the 
overall complication rate would decrease to 9.8%, which would 
be consistent with previously reported complication rates in the 
literature.
Ambulation status was found to be an important predictor 
for medical complications, in which patients with impaired pre-
operative ambulation status had 2.27 times greater odds of medi-
cal complication compared to those who ambulated indepen-
dently (p= 0.02) and was associated with a greater incidence of 
postoperative UTIs specifically (p= 0.004). This finding is sup-
ported by a previous study, which had found that preoperative 
walking disabilities were associated with increased risk of ve-
nous thromboembolic events following spine surgery.19 The 
impaired ambulation status can be a consequence of CSM, but 
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it may also be an indicator for patient frailty.16,20 The observed 
relationship between ambulatory status and UTIs may be ex-
plained by several mechanisms. Patients with significant CSM 
causing impaired ambulation are often observed to have neuro-
genic bladder symptoms associated with their condition as well. 
Though the goal of PCF surgery is to relieve cord compression 
and, therefore, bladder dysfunction, in some cases incomplete 
decompression can lead to continuation of preoperative symp-
toms. Alternatively, prior work has shown that poor mobility is 
itself associated with UTIs by allowing patients to independent-
ly void and decrease periods of urinary stasis, which is a predis-
posing factor to infection.21 Furthermore, patients with impaired 
mobility are more likely to have urinary catheter for longer pe-
riods of time, which may also increase the risk of UTI. Thus, 
loss of independent ambulation may serve as a predictor of 
postoperative complications and poor outcomes, establishing 
its importance as a potentially modifiable risk factor. “Prehabil-
itation” programs, which seek to improve surgical outcomes by 
providing preoperative physical and nutritional therapy to frail 
patients, may be an apt intervention to address the increased 
risk conferred by loss of mobility.
EBL is a well-established risk factor for perioperative compli-
cation in spine surgery.4,22,23 Our study supports this association, 
finding that EBL > 500 mL is associated with more than three-
fold greater odds of medical complication (p= 0.02). Increased 
EBL was also associated with a small, but statistically significant 
increase in the odds of overall complication (p= 0.03). Blood 
loss may lead to adverse events through a variety of pathways, 
from fluid shifts affecting cardiac, pulmonary, and renal status 
to impairment of the immune system leading to postoperative 
infections.24 The association found in this study between larger 
blood loss and acute anemia is evident, however the observed 
relationship with new neurologic deficits after surgery is less 
obvious. For some patients, EBL may serve as a proxy for inva-
siveness and complexity of surgery, which could predispose pa-
tients to nerve injury and associated deficits. This result sug-
gests that minimizing EBL may help to decrease postoperative 
complications.25
Preoperative narcotic use was identified as an important pre-
dictor of postoperative complications in our study. One previ-
ous study found that narcotic use was not associated with com-
plications up to 90 days after surgery.26 However, a recent retro-
spective database analysis by Jain et al.27 reported that preopera-
tive opioid use was associated with an eightfold increase in odds 
of complication following posterior lumbar fusion surgery. The 
present study lends support to the latter finding, which may be 
explained through several biological mechanisms. Activation of 
cutaneous opioid receptors has been shown to interfere with 
angiogenesis, delay and reduce neutrophil and macrophage re-
cruitment to the surgical site, and alter neuropeptide signaling 
that is essential for wound healing.28-30 The difference in effect 
size (OR of 2.43 for surgical complication and 1.97 for overall 
complication, versus 8.08 in previous work) may be attributed 
to a shorter follow-up time capturing fewer complications in 
narcotic-using patients in our study (30 days versus 90 days). 
This likely explains the lack of significant associations with spe-
cific postoperative complications as well. For example, the inci-
dence of surgical site infection was greater in the narcotic use 
group and, though this finding is supported by our mechanistic 
understanding of wound healing, it did not reach significance 
(Supplementary Table 4).
Antidepressant use was the only protective factor for surgical 
complication identified. Depression and anxiety have well-doc-
umented associations with poor outcomes after spine surgery, 
having been shown to lead to increased Nurick scores and rates 
of delirium.31,32 Prior research has revealed that treatment of 
these disorders with antidepressants attenuates this increase in 
complications.33 This finding highlights the importance of pre-
operative treatment of psychiatric conditions.
Several other risk factors previously linked to postoperative 
complication were not found to be independent predictors in 
this study. While diabetes is often identified as a modifiable risk 
factor with a significant role in the incidence of complication, it 
did not emerge as a significant predictor in the univariate or 
multivariate analysis here.34-36 Likewise, many studies cite body 
mass index (BMI) as an independent predictor of surgical site 
infection, though recent work has repudiated this finding.37-40 
In this study, BMI was included in the multivariate models for 
medical and overall complication, but its independent contri-
bution was found to be insignificant (p= 0.33 and p= 0.98, re-
spectively).
The present study has several limitations. As a retrospective 
study relying on chart review for data collection, it is subject to 
errors in the medical charts (i.e., missed diagnoses) and to the 
interpretation of the information therein. Underestimation of 
complications is another concern, as patients may seek care 
elsewhere within 30 days of surgery. Finally, our definition of 
preoperative opioid use did not include the actual dose infor-
mation and is thus an incomplete metric of the extent of patients’ 
actual opioid use.
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CONCLUSION
Preoperative narcotic use and impaired ambulation were 
identified as modifiable risk factors for complications after 
PCLF. Preoperative “Opioid-weaning” and “Prehabilitation” 
programs may help to reduce postoperative complications. In-
creased EBL and operative time also increased the odds of short-
term complications after surgery. Spine surgeons should keep 
these results in mind when counseling patients regarding risks 
associated with PCLF.
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Supplementary Table 4. Surgical and overall complications 
associated with preoperative narcotic use
Complication No Yes p-value
Anemia 4 (4.2) 3 (3.0) 0.92
UTI 1 (1.1) 4 (4.0) 0.41
Arrhythmia 3 (3.2) 1 (1.0) 0.56
DVT 2 (2.1) 1 (1.0) 0.95
PE 1 (1.1) 0 (0) 0.97
Pneumonia 1 (1.1) 1 (1.0) > 0.99
Sepsis 1 (1.1) 0 (0) 0.97
CVA 0 (0) 1 (1.0) > 0.99
Cardiac arrest 0 (0) 1 (1.0) > 0.99
Death 0 (0) 1 (1.0) > 0.99
Surgical site infection 2 (2.1) 5 (5.0) 0.50
Dysphagia 2 (2.1) 3 (3.0) > 0.99
Vocal paralysis 1 (1.1) 0 (0) 0.97
New neurologic deficit 8 (8.4) 8 (7.9) > 0.99
Durotomy 3 (3.2) 8 (7.9) 0.26
Seroma 4 (4.2) 0 (0) 0.05
Pain control difficulty 1 (1.1) 3 (3.0) 0.66
Implant malposition 1 (1.1) 2 (2.0) > 0.99
Revision within 30 days 1 (1.1) 2 (2.0) > 0.99
Values are presented as number (%).
UTI, urinary tract infection; DVT, deep vein thrombosis; PE, pul-
monary embolism; CVA, cerebrovascular accident.
*p < 0.05.
Supplementary Table 1. Medical complications associated with 
impaired ambulation
Complication Independent  ambulation
Impaired  
ambulation p-value
Anemia 5 (3.7) 2 (3.3) > 0.99
UTI 0 (0) 5 (8.2) 0.004*
Arrhythmia 2 (1.5) 2 (3.3) 0.78
DVT 1 (0.7) 2 (3.3) 0.47
PE 0 (0) 1 (1.6) 0.68
Pneumonia 2 (1.5) 0 (0) 0.85
CVA 0 (0) 1 (1.6) 0.68
Cardiac arrest 0 (0) 1 (1.6) 0.68
Death 0 (0) 1 (1.6) 0.68
Values are presented as number (%).
UTI, urinary tract infection; DVT, deep vein thrombosis; PE, pul-
monary embolism; CVA, cerebrovascular accident.
*p < 0.05.
Supplementary Table 2. Medical and overall complications 
associated with estimated blood loss
Complication ≤ 500 mL > 500 mL p-value
Anemia 3 (1.8) 4 (14.3) 0.006*
UTI 4 (2.4) 1 (3.6) > 0.99
Arrhythmia 3 (1.8) 1 (3.6) > 0.99
DVT 1 (0.6) 2 (7.1) 0.07
PE 1 (0.6) 0 (0) > 0.99
Pneumonia 2 (1.2) 0 (0) > 0.99
Sepsis 1 (0.6) 0 (0) > 0.99
CVA 0 (0) 1 (3.6) 0.31
Cardiac arrest 0 (0) 1 (3.6) 0.31
Death 0 (0) 1 (3.6) 0.31
Surgical site infection 7 (4.2) 0 (0) 0.58
Dysphagia 2 (1.2) 3 (10.7) 0.02
Vocal paralysis 0 (0) 1 (3.6) 0.31
New neurologic deficit 10 (6.0) 6 (21.4) 0.02*
Durotomy 10 (6.0) 1 (3.6) 0.95
Seroma 4 (2.4) 0 (0) 0.92
Pain control difficulty 4 (2.4) 0 (0) 0.92
Implant malposition 1 (0.6) 2 (7.1) 0.07
Revision within 30 days 1 (0.6) 2 (7.1) 0.07
Values are presented as number (%).
UTI, urinary tract infection; DVT, deep vein thrombosis; PE, pul-
monary embolism; CVA, cerebrovascular accident.
*p < 0.05.
Supplementary Table 3. Surgical complications associated with 
operative time
Complication > 240 min ≤ 240 min p-value
Surgical site infection 4 (3.0) 3 (4.9) 0.06
Dysphagia 2 (1.5) 3 (4.9) 0.01*
Vocal paralysis 0 (0) 1 (1.6) > 0.99
New neurologic deficit 9 (6.7) 7 (11.5) 0.28
Durotomy 9 (6.7) 2 (3.3) 0.42
Seroma 4 (3.0) 0 (0) 0.34
Pain control difficulty 4 (3.0) 0 (0) 0.34
Implant malposition 1 (0.7) 2 (3.3) 0.07
Revision within 30 days 1 (0.7) 2 (3.3) 0.07
Values are presented as number (%).
*p < 0.05.
